Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology (Q38803449)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 April 2016

Language	Label	Description	Also known as
English	Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology	scientific article published on 9 April 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

0 references

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Luigi Francesco Morrone

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Adamasco Cupisti

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sandro Mazzaferro

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Mario Cozzolino

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Pergiorgio Bolasco

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Corrado Camerini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Giuseppe Cianciolo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Andrea Galassi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Domenico Russo

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Luigi Russo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

9 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Journal of Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

305-328

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Vitamin D deficiency

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Contributions of sunlight and diet to vitamin D status

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: promising new therapeutic targets?

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Variants Fok1 and Bsm1 on VDR are associated with the melanoma risk: evidence from the published epidemiological studies

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D and melanoma.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D metabolism, mechanism of action, and clinical applications

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D 25-hydroxylase - Four decades of searching, are we there yet?

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Regulation of the extrarenal CYP27B1-hydroxylase

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D: metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin d binding protein and bone health

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Regulation of vitamin D metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Studies upon the mode of action of vitamin D: The influence of vitamin D on the absorption of calcium and phosphorus in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Evidence for a direct action of cholecalciferol and 25-hydroxycholecalciferol on the renal transport of phosphate, sodium, and calcium

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D activities for health outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D receptor activation and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D and cancer mortality: systematic review of prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

IOF position statement: vitamin D recommendations for older adults

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Ergocalciferol and cholecalciferol in CKD.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Prevention of secondary hyperparathyroidism in hemodialysis patients: The key role of native vitamin D supplementation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D metabolites and/or analogs: which D for which patient?

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Which vitamin D in CKD-MBD? The time of burning questions

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKD.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effects of paricalcitol on urinary calcium in patients with chronic kidney disease stages 2 - 4.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Differential effects of Vitamin D analogs on bone formation and resorption

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Age and association of kidney measures with mortality and end-stage renal disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Oral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Active vitamin D treatment for reduction of residual proteinuria: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The beneficial impact of vitamin D treatment in CKD patients: what's next?

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Blood pressure is correlated with vitamin d(3) serum levels in dialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Ultraviolet B and blood pressure

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D therapy in chronic kidney disease and end stage renal disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Nutritional vitamin D supplementation in dialysis: a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D receptor activation and survival in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

High prevalence of vitamin D deficiency in African American kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

25-hydroxyvitamin D deficiency in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D status and outcomes after renal transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Rapid calcitriol increase and persistent calcidiol insufficiency in the first 6 months after kidney transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

FGF-23 Levels before and after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Persistence of bone and mineral disorders 2 years after successful kidney transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The pleiotropic effects of vitamin D in bone

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effect of kidney transplantation on bone

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Bone disease in patients with long-term renal transplantation and normal renal function.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Cause of Death With Graft Function Among Renal Transplant Recipients in an Integrated Healthcare System

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Significance and management of proteinuria in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D status in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Paricalcitol for secondary hyperparathyroidism in renal transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,0

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Fragility fractures and osteoporosis in CKD: pathophysiology and diagnostic methods.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Osteoporosis: now and the future

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Recent advances in the noninvasive diagnosis of renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

When, how, and why a bone biopsy should be performed in patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Bone alkaline phosphatase in CKD-mineral bone disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Bisphophonates in CKD patients with low bone mineral density.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The effect of oral loading doses of cholecalciferol on the serum concentration of 25-OH-vitamin-D.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vascular calcification in chronic kidney disease: an update.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D deficiency and risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The vulnerable patient with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

The dualistic role of vitamin D in vascular calcifications

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Active serum vitamin D levels are inversely correlated with coronary calcification

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Role of vitamin D receptor activators on cardiovascular risk

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

New vitamin D analogs and changing therapeutic paradigms

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Warfarin-induced artery calcification is accelerated by growth and vitamin D

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D receptor activators can protect against vascular calcification

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Differential effects of vitamin D analogs on vascular calcification

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Determinants of progressive vascular calcification in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D affects survival independently of vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

A bimodal association of vitamin D levels and vascular disease in children on dialysis

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Paricalcitol Versus Ergocalciferol for Secondary Hyperparathyroidism in CKD Stages 3 and 4: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Vitamin D levels and patient outcome in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Longitudinal Analysis of Vascular Function and Biomarkers of Metabolic Bone Disorders before and after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0305-6

21 January 2018

Adynamic bone disease: an update and overview.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of vitamin D metabolites on bovine parathyroid hormone release in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure. A synergistic effect with r-HuEpo

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weekly high-dose ergocalciferol to correct vitamin D deficiency/insufficiency in hemodialysis patients: a pilot trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of changing vitamin D levels on anemia in chronic kidney disease patients: a retrospective cohort review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D: a d-lightful solution for health

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of vitamin D in melanoma prevention: evidence and hyperbole

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunlight, ultraviolet radiation, vitamin D and skin cancer: how much sunlight do we need?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histological, radiological, and biochemical features of the adynamic bone lesion in continuous ambulatory peritoneal dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whether vitamin D3 is effective in reducing proteinuria in type 2 diabetic patients?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of vitamin D receptor activators on vascular calcification in uremic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunlight, vitamin D and malignant melanoma: an update.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D status and mortality of German hemodialysis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The case against ergocalciferol (vitamin D2) as a vitamin supplement

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D levels and early mortality among incident hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Prevalence of histological types of bone disease in a hemodialysis center limiting the oral intake of aluminum hydroxide]

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CKD-mineral and bone disorder management in kidney transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of BMI on cardiovascular events, renal function, and coronary artery calcification

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

24-Hydroxylation of 1,25-dihydroxyergocalciferol. An unambiguous deactivation process.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose calcitriol versus placebo in patients with predialysis chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fate of bone after renal transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality risk among hemodialysis patients receiving different vitamin D analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of hip fracture among dialysis and renal transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pleiotropic Activities of Vitamin D Receptors - Adequate Activation for Multiple Health Outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current understanding of the molecular actions of vitamin D.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27062486

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40620-016-0305-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27062486%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38803449&oldid=2202087111"